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ABSTRACT  We  report on the  biochemical  and  immunological  properties  as well  as on  the 
cellular  and  subcellular  distribution  of two  proteins,  called  secretogranins  I  and  II.  These 
proteins specifically occur in a wide variety of endocrine and neuronal cells that package  and 
sort regulatory peptides into secretory granules.  Both secretogranins take the same intracellular 
route as the peptides and are also sorted into secretory granules.  Secretogranins  I and  II are 
biochemically  and  immunologically  distinct  proteins  and  differ  from  chromogranin  A.  Yet, 
these three proteins are similar to each  other in many respects  and therefore constitute  one 
class of proteins. A  remarkable feature of this protein class is a very acidic  pl, brought about 
by a high content of acidic amino acids as well as by phosphorylation on serine  and sulfation 
on  tyrosine  and  O-linked  carbohydrate.  As  a  result,  this  class of  proteins  has  a  high  net 
negative charge even at the acidic  pH of the trans Golgi cisternae.  We discuss the possibility 
that this property of the proteins may point to a role in the packaging of regulatory peptides 
into secretory granules. 
The  intracellular process by which  peptide hormones and 
neuropeptides are secreted has been intensively studied, and 
many aspects  of this  process have been characterized (for 
reviews see references 6,  14, and 43). However, some impor- 
tant questions have remained unanswered, such as how pep- 
tides that are secreted by the regulated pathway (16, 32) are 
packaged and  sorted into secretory granules.  It can be ex- 
pected that the identification of specific features of the secre- 
tory process that  are common to endocrine and  neuronal 
cells, irrespective of the specific peptide secreted, will help to 
elucidate the unknown mechanisms of packaging and sorting 
of regulatory peptides. 
We have been interested (a) in posttranslational modifica- 
tions that specifically take place at the intraceUular sites where 
packaging and sorting of peptides are known to occur, and 
(b) in the possible existence of target proteins for these mod- 
ifications that are common to different peptide-secreting en- 
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docrine and neuronal cells. Previous work has shown that the 
covalent modification of secretory proteins by sulfation of 
tyrosine (18, 20) apparently occurs in the Golgi complex at 
the level of the trans cisternae (28; Baeuerle, P. A., and W. B. 
Huttner, unpublished observations). The search for the major 
tyrosine-sulfated proteins in a model neurosecretory cell line, 
the rat pheochromocytoma  cell PC 12, led to the identification 
of two  previously uncharacterized secretory proteins,  one 
consisting of a pair of homologous polypeptides of 113/105 
kD,  and the other one consisting of a  pair of homologous 
polypeptides of 86/84 kD (27). 
Other studies,  investigating sulfated macromolecules in se- 
cretory granules,  led  to  the  identification  of a  previously 
unknown secretory protein of the bovine anterior pituitary 
(36, 48). An immunologically related protein appeared to be 
present in the adrenal medulla (37),  the tissue from which 
PC12  cells  are  derived. We  have  recently shown  that the 
anterior pituitary protein also consists of  a pair of  homologous 
polypeptides of 86/84 kD that contain the sulfate bound to 
tyrosine residues.  These results suggested  that the 86/84-kD 
1999 protein of  PC12 cells may be identical to the 86/84-kD protein 
of the  anterior pituitary.  Moreover,  since  this  protein  was 
found in secretory granules of different endocrine cells of the 
anterior pituitary (38), we considered the possibility that this 
protein may not only occur in the anterior pituitary but may 
be common to a wide variety of endocrine and neuronal cells 
that secrete peptides by the regulated pathway. 
Recent reports have shown that chromogranin A, a 75-kD 
secretory protein first found in chromaffin granules (for re- 
views see references 44 and 45),  occurs in many but not all 
endocrine and neuronal cells (7, 8, 33, 41). Considering these 
reports and our previous results, it occurred to us that (a) the 
86/84-kD  protein,  the  l13/105-kD  protein,  and  chromo- 
granin A  may be members of one class of proteins, (b) the 
distribution  of this  protein  class  may be  more widespread 
than that of any one member, and (c) the individual members 
may share certain properties, the identification of which may 
provide essential clues as to their function. 
We now report that the  86/84-kD protein  and the  113/ 
105-kD protein indeed occur in secretory granules of a wide 
variety of peptide-secreting endocrine and neuronal cells, and 
that their cellular distribution is partly overlapping and partly 
complementary.  In  view  of their  cellular  and  subcellular 
localization, we have named the  113/105-kD protein secre- 
togranin  I  and the  86/84-kD  protein  secretogranin II. The 
results demonstrate that secretogranin I, secretogranin II, and 
chromogranin  A  are  distinct  proteins  but  are  sufficiently 
similar in many respects to be regarded as one protein class. 
MATERIALS  AND  METHODS 
Tissue Preparation  and Subcellular  Fractionation:  Bovine 
and rat tissues were dissected, frozen in liquid nitrogen, crushed on dry ice to 
a  fine  powder,  homogenized  1:10 (wt/vol)  in  sample  buffer  (25, 27), and 
immediately  boiled. Chromaffin  granules were isolated from  bovine adrenal 
medulla as described (3). The isolated granules were lysed by resuspension in 
20 mM Tris-HC1, pH 7.4, 5 mM 2-mercaptoethanol,  I mM phenylmethylsul- 
fonyl fluoride, followed by two cycles of freezing and thawing. The suspension 
was centrifuged for 1 h at 140,000 g, and the soluble fraction was collected. In 
some experiments,  the  heat-stable  protein  fraction  was  prepared  from  the 
soluble fraction of chromaffin granules as described below. 
Purification  of Secretogranins I and II and Chromogranin 
A:  Tissues were homogenized  l:10 (wt/vol) in 20 mM Tris-HCl, pH 7.4, 5 
mM 2-mercaptoethanol,  1 mM phenylmethylsulfonyl fluoride, and the homog- 
enates were centrifuged at 140,000 g for 1 h. To the soluble fractions obtained, 
NaCI was added to a final concentration  of 150 mM, followed by boiling for 5 
min and centrifugation  as above. The resulting supernatant  is referred to as 
heat-stable protein  fraction. For polyacrylamide gel electrophoresis, the heat- 
stable proteins, highly enriched in secretogranins I and 11 and chromogranin  A, 
were concentrated  by acetone  precipitation  and resuspended either in sample 
buffer or in lysis buffer (35). 
For raising antisera,  bovine  secretogranin  Ii was purified  from  the heat- 
stable protein fraction of anterior pituitary by DEAE-cellulose chromatography 
(37)  and  preparative  two-dimensional  PAGE.  Bovine  secretogranin  1 and 
chromogranin  A were purified from the soluble fraction ofchromaffin granules 
by preparative two-dimensional PAGE. Rat secretogranins I and II were puri- 
fied from  PCI2  cells as described  in detail  elsewhere (Hille, A.,  and W.  B. 
Hutmer,  unpublished  observations).  Briefly, the  purification  procedure  in- 
volved hypotonic  lysis of PCI2  cells, heat  treatment  of the  soluble protein 
fraction,  DEAE-cellulose chromatography,  and  preparative  two-dimensional 
PAGE. 
For the experiment  shown in Fig. 8, secretogranin  I and I1 were enriched 
from various rat tissues as follows. Tissues were homogenized  l: l0 (wt/vol) in 
50  mM  Tris-HCI,  pH  7.5, 1%  (wt/vol)  SDS,  5  mM  EDTA,  and 0.5  mM 
phenylmethylsulfonyl fluoride, boiled for 5 min, and centrifuged at 10,000 rpm 
for 30 rain.  Aliquots of the supernatants  (2--4 mg total protein) were diluted 
1:10 in 50  mM Tris-HCl,  pH 7.5, 1% (wt/vol)  Nonidet  P-40, 0.5% (wt/vol) 
deoxycholate, and 5 mM EDTA, and incubated with 25 #1 of anti-rat secreto- 
granin I antiserum plus 25/al of  anti-rat secretogranin 11 antiserum (see below). 
The immune complexes were absorbed to Staphylococcus aureus cells (Pansor- 
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bin, Calbiochem-Behring Corp., LaJolla, CA) as described (22) and extensively 
washed. Secretogranins I and II were separated from the Staphylococcus aureus 
cells and the immunoglobulins  by boiling in the presence of 20 mM Tris-HCl, 
pH 7.4, 150 mM NaCI, 3% (vol/vol) 2-mercaptoethanol,  and  l0 mM EDTA, 
followed by centrifugation  in a microfuge (Eppendorf,  Hamburg,  FRG).  The 
heat-stable proteins present in the resulting supernatant  were precipitated with 
acetone, solubilized in sample buffer, and subjected to SDS PAGE followed by 
immunoblotting (see below). 
Antisera:  After  preparative  two-dimensional  PAGE,  gels were  either 
stained  by the  KCI method  (17) or fixed, stained  with Coomassie Blue, and 
destained (27). Pieces containing  either rat or bovine secretogranin I, secreto- 
granin II, or chromogranin A were cut from the gels, homogenized in a small 
volume  of phosphate-buffered  saline  (PBS), and  used  for immunization  of 
rabbits. Gel homogenates were emulsified l: l with complete Freund's adjuvant 
for the first injection and with incomplete  Freund's adjuvant  for the booster 
injections. 50- 100 ~g of purified protein were used per injection. 
Cell  Culture,  Labeling,  and  Release of  Secretogranins: 
PCI2 cells were grown as previously described (27). The primary culture  of 
bovine adrenal  medullary  cells was performed  as described (l).  [35S]Sulfate- 
and  [32p]phosphate-labeling of cell cultures  was performed  for  18-24  h  as 
described (27). In the case of PCI2 cells, the medium was supplemented  with 
10%  dialyzed horse serum  and  5%  dialyzed  fetal calf serum;  in the  case of 
adrenal  medullary  cells, the medium was supplemented  with  1.5% dialyzed 
horse serum,  100 U/ml penicillin, and 0.1 mg/ml streptomycin sulfate (P0781, 
Sigma Chemie,  Tautkirchen,  FRG).  Dialysis of the sera was against PBS for 
sulfate labeling and against HEPES-buffered saline for phosphate  labeling. In 
some experiments,  [3SS]sulfate labeling  of adrenal  medullary  cells was per- 
formed in the presence of tunicamycin  (Boehringer Mannheim Biochemicals, 
Mannheim,  FRG) (1.5 ug/ml). 
Uncoated  35-ram dishes containing  l  x  l06 [aSS]sulfate-labeled PCI2 cells 
were washed with Dulbecco's modified Eagle's medium (Gibco Europe, Karls- 
tube,  FRG) and  incubated  for 15  rain  in 0.5  ml of release medium (10 mM 
HEPES, pH 7.2, 2.2 mM CaCI2, 0.33 mM Na2HPO~, 0.44 mM KH2PO4, 4.2 
mM NaHCO3, 5.6 mM glucose, and either  127 mM NaCl/5  mM KCI, 77 mM 
NaCl/55  mM KC1, or 67 mM NaCl/55  mM KCI/10 mM MgCl2). The release 
medium was collected and centrifuged at room temperature  for 5 min at  100 
g:, the supernatant  was further cleared by centrifugation  at 4"C for 30 min at 
100,000 g. The cells attached to the dish were lysed and collected in 0.5 ml of 
50 mM Tris-HC1, pH 7.5, 0.5% (wt/vol) Triton  X-100, 150 mM NAG1, 5 mM 
EDTA, and 0.02% NAN3. The suspension was rapidly frozen, thawed, sonicated 
for l0 s, centrifuged at 4"C for 30 min at 43,000 g, and the supernatant  was 
collected.  Aliquots  of this  supernatant  (cell extract)  (10  ~l,  0.23 gg/ml of 
protein)  and  of the release medium (200 ul) were incubated  with  15  ~l of a 
mixture of anti-rat secretogranin I and anti-rat secretogranin II antisera in the 
presence of 0.5% (wt/vol)  Triton  X-100 and  150 mM NaCl. The amount of 
mixed antisera was sufficient to bind all of secretogranins 1 and II present in 
the samples. Immune complexes were collected by binding to Staphylococcus 
aureus cells (22), solubilized in sample buffer, and subjected to SDS PAGE. 
[3~S]Sulfate-labeled secretogranins I and I! were cut from the gel and quantitated 
by liquid scintillation counting. 
In  Vitro  Translation  of 5ecretogranins  I  and  I1:  Free  and 
membrane-bound polysomes from PC I2 were prepared as described (31), with 
minor modifications. The composition of buffer A was changed to 0.3 M KCI, 
5 mM MgC12, 0.25 M sucrose, and 50 mM Tris-HCl, pH 7.4 and that of buffer 
B to 0.3 M NaCl, 5 mM MgCl2, and 50 mM Tris-HCl, pH 7.4. 5 ×  l0  s PCI2 
cells were washed with Dulbecco's  modified Eagle's medium and pelleted by 
centrifugation.  The cell pellet was frozen in liquid  nitrogen, homogenized  in 
15  ml  of buffer  A,  centrifuged  for  l0  min at  12,000 g,  and  the  resulting 
supernatant  was subjected to discontinuous  sucrose gradient  centrifugation. 
The  pellet containing  free polysomes was resuspended  in  50 ~l of buffer  B 
(A26o/A28o =  1.810). The  material  at  the  1.0-2.0  M  sucrose  interface  that 
contained  bound polysomes was collected, incubated  in the  presence of 1% 
(wt/vol)  Triton  X-100 and  1% (wt/vol) deoxycholate for  l  h at 4"C, layered 
over 20 ml of 2.0 M sucrose in buffer A, and centrifuged for 16 h at 95,000 g. 
The pellet containing  bound polysomes was resuspended in 50 ul of buffer B 
(A26o/A2s0 =  1.634). In vitro translation  was performed as described (31). One 
A26o unit of polysomes and  100 uCi of [aSS]methionine (800 Ci/mmol) (New 
England  Nuclear,  Du  Pont,  Dreieich,  FRG) were  used  per reaction.  After 
incubation  for 90 rain at 25"C, reactions were terminated  by freezing. Samples 
were lyophilized, solubilized in lysis buffer, and aliquots were analyzed by two- 
dimensional  PAGE followed by fluorography. 
SDS PAGE, Two-dimensional PAGE, and Immunoblotting: 
SDS PAGE and two-dimensional PAGE were performed according to Laemmli 
(25) and O'Farrell (35), respectively. For satisfactory resolution ofsecretogran- 
ins I and II and chromogranin  A, a combination  of ampholytes (LKB, Griifelf- 
ing, FRG) was used for isoelectric focusing as described previously (38). Gels were fixed, stained, destained,  and fluorographed as described (27). Immuno- 
blotting after SDS PAGE or two-dimensional PAGE was performed as described 
(5), with the modifications described elsewhere (30). All antisera were used at 
a 1:100 dilution. 
Tryptic Fingerprinting:  Proteins  were excised from fixed, stained, 
destained,  and  dried  two-dimensional  polyacrylamide  gels and  individually 
subjected to radioiodination  and tryptic  fingerprinting as described (11), with 
minor modifications (38). 
Tyrosine Sulfate and Phosphoamino Acid Analysis:  [3~S]- 
Sulfate-labeled and  [32p]phosphate-labeled proteins  were excised from  fixed, 
stained,  destained,  and dried  two-dimensional  polyacrylamide  gels and sub- 
jected  to tyrosine  sulfate analysis (21) and phosphoamino acid analysis (19), 
respectively. 
Amino  Acid Analysis:  Secretogranin  II was purified  from bovine 
anterior  pituitary,  eluted from preparative  SDS polyacrylamide gels, and pre- 
cipitated by acetone as described previously (37). Material eluted and precipi- 
tated  from an equal quantity of a blank  gel was analyzed as a control.  The 
precipitates were hydrolyzed for 18 h in 6 N HCl at  110*C. The hydrolyzates 
were dried, re-dissolved in 0.2 M citrate buffer, pH 2.2, and amino acids were 
then analyzed  in  a  Multichrom  M  Beckman  automatic  analyzer  (Beckman 
Instruments. Inc., Palo Alto, CA) according to the method of Spackman et al. 
(42). Amino acid values obtained  for secretogranin  lI were corrected for those 
obtained for the gel blank. 
Immunocytochemistry:  Anterior  pituitaries, dissected from female 
rats, were immediately  fixed in ice-cold formaldehyde,  postfixed in osmium 
tetroxide, dehydrated, and embedded in Epon (38). In other experiments, male 
and  female  rats  were  anesthetized  and  transcardially  perfused  with  saline, 
followed by perfusion  with  120  mM phosphate buffer, pH 7.4, 4%  (wt/vol) 
formaldehyde,  and  2.5% (wt/vol)  polyvinyl  pyrrolidon.  Tissues  were  then 
dissected, incubated  for 4  h in the same ice-cold fixative, and subsequently 
either  passed  through a  series of increasing  sucrose  solutions  and  used  to 
prepare  frozen sections (29) or dehydrated  and embedded  in Epon.  Indirect 
immunofluoreseence  on plastic sections, after removal of Epon, and on frozen 
sections was performed  as described  (38), using rhodamine-conjugated  goat 
lgG directed against rabbit lgG (Cappel Laboratories, Cochranville, PA) in the 
second antibody  step. lmmunolabeling of frozen sections of the brain,  using 
horseradish peroxidase-conjugated  goat F(abh anti-rabbit IgG (Institute  Pas- 
teur,  Paris, France) in the second antibody  step, was performed  as described 
(9). 
RESULTS 
Presence of Secretogranin I, Secretogranin  II, and 
Chromogranin A  in Anterior Pituitary 
and Adrenal Medulla 
Secretogranins I and II were previously shown to remain in 
solution when the soluble fraction of a PC 12 cell lysate was 
boiled  (26).  In  the  present  study,  we  have  exploited  this 
property to obtain fractions greatly enriched in secretogranin 
I, secretogranin II, and chromogranin A. To demonstrate the 
presence of all three proteins in both anterior pituitary and 
adrenal medulla, the heat-stable protein fractions of bovine 
anterior pituitary, bovine chromafiin granules, and as refer- 
ence,  [3SS]sulfate-labeled PC I2  cells  were analyzed by two- 
dimensional PAGE (Fig.  1). In mixing experiments, secreto- 
granin II (arrows) of PC12 cells (Fig.  l B) co-migrated with 
secretogranin II  of the  bovine anterior pituitary (Fig.  1A). 
Secretogranin II  was  the  major  heat-stable  protein  of this 
tissue.  Secretogranin II  was  also  present,  though  in  much 
smaller amounts,  among the heat-stable proteins of bovine 
chromaffin granules (Fig. l, C-E; compare also Fig. 2A). Like 
secretogranin II, secretogranin I  (arrowheads) was observed 
not only in PCI2 cells (Fig.  l, B and D) but also (as a single 
105-kD polypeptide) in the bovine anterior pituitary (Fig. 1  A) 
and in bovine chromaffin granules (Fig.  1  C). Chromogranin 
A (open arrows), in turn, was seen not only in bovine chro- 
muffin  granules  (Fig.  1 C),  but  also,  though  in  smaller 
amounts, among the heat-stable proteins of the bovine ante- 
rior pituitary (Fig.  l, A and E). 
FIGURE  1  Presence ofsecretogranin I, secretogranin  II, and chrom- 
agranin A in anterior pituitary and adrenal medulla. The heat-stable 
protein fractions of bovine anterior pituitary of chromaffin granules 
from bovine adrenal medulla, and of [3SS]sulfate-labeled PC12 cells 
were mixed. (A and B) Anterior pituitary (70 #g protein) plus PC12 
cells (5 #g protein): (C and D) adrenal medulla (50 #g protein) plus 
PC12 cells (5/.tg  protein): (E) anterior pituitary (30 #g protein) plus 
adrenal medulla (50 #g protein).  Samples were analyzed by two- 
dimensional PAGE, followed by Coomassie  Blue staining (A, C and 
E) and fluorography (B and D). Arrowheads, 10S-kD component of 
secretogranin  I; arrows, secretogranin  II; open arrows, chromagranin 
A.  Note that the bovine secretogranin  I apparently lacks the 113- 
kD  component  seen  in the  rat  secretogranin  I.  The positions  of 
molecular weight standards are indicated. 
Secretogranin  I, Secretogranin  II, and 
Chromogranin A Are Three Biochemically 
Distinct  Proteins 
Secretogranin  I, secretogranin  II, and chromogranin A  of 
the bovine adrenal  medulla and of the bovine anterior pitui- 
tary were separated by two-dimensional PAGE (Fig. 2, A and 
B, respectively),  individually radioiodinated, and analyzed by 
tryptic  fingerprinting  (Fig.  2, square panels).  For each of the 
three  proteins,  the  fingerprint  of the  adrenal  medulla  form 
was virtually  identical to that  of the anterior  pituitary  form. 
ROSA  ET  AL.  Secretograninslandll  2001 FIGURE 2  Secretogranin  I, secretogranin  II, and chromogranin A are three distinct proteins.  The heat-stable  protein fractions of 
chromaffin granules  from  bovine adrenal medulla (A) and of bovine anterior pituitary (B) were separated  by two-dimensional 
PAGE followed by Coomassie  Blue staining as shown. Individual proteins, indicated in panels A and B, were radioiodinated and 
analyzed by tryptic fingerprinting followed by fluorography (square  panels). Arrowheads point to secretogranin  I (Sgl)  and  its 
related polypeptides; the three unlettered arrowheads in A indicate p63,  p45, and p43, the fingerprints of which are not shown. 
Arrows point to secretogranin  II (Sgll)  and its related  polypeptides. Open arrows  point to chromogranin A (CgA) and its related 
polypeptides; the unlettered open arrow in A indicates p51, the fingerprint of which is not shown. The two-dimensional separation 
system used for the radiolabeled tryptic peptides is shown in the diagram  in the top right corner. TLE,  thin-layer electrophoresis; 
cathode on the left. 
However, the fingerprints of the three proteins were clearly 
different from each other. In fact, mixing experiments (not 
shown) indicated that  very few,  if any, of the radiolabeled 
peptides of the three proteins co-migrated exactly. 
Fingerprint analysis was also used to investigate the rela- 
tionship of the various other heat-stable proteins to secreto- 
granins I and II and chromogranin A (Fig. 2). This revealed 
three distinct sets of  proteins: (a) p94, p90, p82, p67, p63 (not 
shown), p54,1945 (not shown), and p43 (not shown) of  adrenal 
medulla were related to secretogranin I; (b) p66 and p64 of 
the anterior pituitary were related to secretogranin II; (c) p92, 
p62, and p51 (not shown) ofchromaffin  granules were related 
to chromogranin A. The results on p62 and p51 confirm those 
of O'Connor and Frigon (34) who refer to these two proteins 
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as chromogranins B and C, respectively. P92 appears to be a 
highly sulfated form of chromogranin A (see Figs. 4 and 6). 
Secretogranin  I, Secretogranin  II, and 
Chromogranin  A Are  Three Immunologically 
Distinct Proteins 
Antisera were raised in rabbits against rat secretogranins I 
and  II  purified  from  PC12  cells,  bovine  secretogranin  II 
purified from anterior pituitary, and bovine secretogranin I 
and  chromogranin  A  purified  from  adrenal  medulla.  To 
ensure purity of  the antigens, these proteins were excised from 
two-dimensional polyacrylamide gels.  One-dimensional im- 
munoblotting of total PC12 cell protein (Fig. 3, lanes 1 and 2) and of total bovine anterior pituitary protein (Fig. 3, lane 
3) showed that the various antisera were specific and recog- 
nized either secretogranin I, secretogranin II, or chromogranin 
A. The use of these antisera in two-dimensional immunoblots 
indicated the presence of three distinct sets of proteins in 
bovine and rat adrenal medulla (Fig. 4) and anterior pituitary 
(data not shown). These data supported the fingerprint results 
(Fig.  2)  on the  relationship of the  various polypeptides to 
FIGURE  3  Specificity of anti- 
sera  raised  against  secreto- 
granin I, secretogranin II,  and 
chromogranin A. Aliquots (100 
/~g protein) of the total homog- 
enate of rat  PC12  cells (lanes 
1 and 2) and of bovine anterior 
pituitary (lane 3) were used for 
one-dimensional immunoblot 
analysis.  Lane 1, anti-rat PC12 
cell secretogranin I antiserum; 
lane 2,  anti-rat  PC12  cell se- 
cretogranin II antiserum; lane 
3,  anti-bovine  adrenal  me- 
dulla  chromogranin  A  anti- 
serum. The positions of secre- 
togranin  I  (Sgl),  secretogranin 
II  (Sgll),  and  chromogranin A 
(CgA) are indicated. Note that the faint band below secretogranin 
II in lane 2 is not chromogranin A  but p66, one of the degradation 
products of secretogranin II (see Fig. 4). 
either secretogranin I, secretogranin II, or chromogranin A. 
It should be noted that the apparent molecular weight of rat 
chromogranin A was higher than that of  bovine chromogranin 
A and was almost identical to that of rat secretogranin II (Fig. 
4,  E  and  H).  The  cross-reactivity of antisera  against  rat 
antigens with the respective bovine antigens was variable, and 
vice-versa. 
In Vitro Translation of Secretogranins I and II 
Free and membrane-bound polysomes of PC 12 cells were 
isolated and,  after solubilization  of membranes,  separately 
used in in vitro translation experiments (Fig. 5). This indicated 
that the 113- and 105-kD components of rat secretogranin I 
and the 86- and 84-kD components of rat secretogranin II 
were synthesized exclusively by polysomes derived from the 
membrane-bound population (Fig.  5 B). Since the mobilities 
of  the in vitro translation products were not identical to those 
of the [35S]sulfate-labeled proteins produced by PC12 cells, 
the identity of the translation products as secretogranins I and 
II was confirmed by immunoprecipitation using specific anti- 
rat secretogranin I and anti-rat secretogranin II antisera (Be- 
nedum, U. M., and W. B. Huttner, unpublished data). 
Secretogranin  I, Secretogranin  II, and 
Chromogranin A Are Phosphorylated 
and Sulfated 
Like chromogranin A  (7), secretogranins  I and II appeared 
FIGURE 4  Immunological  identification  of  bovine and  rat  secretogranin  I-,  secretogranin  II-,  and  chromogranin A-derived 
proteins. Aliquots of either the soluble content of chromaffin granules from  bovine adrenal medulla (A-D)  or the  heat-stable 
protein fraction of the rat adrenal gland (E-H) were used for two-dimensional immunoblot analysis. (A and E) Amido black staining 
of nitrocellulose filters; (B-D and F-H) fluorograms of nitrocellulose filters. (B and F) Anti-bovine (B) and anti-rat (F) secretogranin 
I antiserum;  (C  and  G)  anti-bovine  (C)  and  anti-rat  (G)  secretogranin  II  antiserum;  (D  and  H)  anti-bovine chromogranin A 
antiserum. Arrowheads, secretogranin I (Sgl); arrows, secretogranin II (Sgll);  open arrows, chromogranin A  (CgA);  open arrows 
with asterisk,  highly sulfated form of chromogranin A (see Figs. 2 and 5). 
ROSA ET AL.  Secretogranins  land II  2003 to be rich in acidic amino acid residues since they yielded 
high proportions of glutamic acid and aspartic acid after acid 
hydrolysis (Table I and unpublished results).  As a result, the 
translation products of the secretogranin I-secretogranin II-, 
and chromogranin A-mRNAs are acidic polypeptides (Fig. 5; 
reference 12). We have investigated the posttranslational mod- 
ification of these proteins by phosphorylation and sulfation, 
which would further decrease the isoelectric points of these 
proteins. For this purpose, primary cultures of  bovine adrenal 
medullary cells were labeled with  [32p]phosphate  and  [35S]- 
sulfate.  Analysis of proteins by two-dimensional PAGE indi- 
cated that secretogranins I and II and chromogranin A were 
phosphorylated (Fig. 6A), the phosphate in all three proteins 
being predominantly bound to serine residues and to a small 
extent to threonine, but not to tyrosine, residues (data not 
shown). The phosphorylation of chromogranin A  confirms 
previous results by others (4, 40). 
The  chromogranin  A  spot  also  contained  a  small,  but 
FIGURE  5  In vitro translation of secretogranin I and secretogranin 
II  of  PC12  cells.  Free and  bound  polysomes were  isolated  from 
PC12 cells and incubated in the presence of [3SS]methionine. Pro- 
teins translated from free polysomes (A) and from bound polysomes 
(B) were analyzed by two-dimensional PAGE, followed by fluorog- 
raphy. Arrowheads,  precursors of secretogranin I; arrows,  precur- 
sors of secretogranin II. 
significant amount of radioactive sulfate (Fig. 6B). Interest- 
ingly,  p92  (indicated  in  Fig.  6B  by the  open  arrow with 
asterisk), which yielded the same fingerprint as chromogranin 
A (Fig.  2) and was specifically  recognized by anti-chromo- 
granin A  antibodies (Fig.  4),  contained a  large  amount  of 
radioactive sulfate,  suggesting  that  it was a  highly sulfated 
form of chromogranin A. Secretogranins I and II were clearly 
sulfated (Fig. 6B). The radioactive sulfate incorporation into 
secretogranins I and II and chromogranin A was not reduced 
by labeling cells in the presence of tunicamycin, an inhibitor 
of N-glycosylation (data  not shown).  The sulfate found in 
chromogranin A and in the highly sulfated form of chromo- 
granin  A  was  not  recovered to  any  significant  extent  as 
tyrosine sulfate (Table II).  Together with  the  tunicamycin 
result, this indicated that the sulfate was bound to O-linked 
carbohydrate.  A  large  portion,  but  not  all,  of the  sulfate 
TABLE  I.  Ammo  Acid Composition of Bovine Secretogranin Ih 
Comparison with That of Chromogranin  A 
Residues/100 residues 
Secretogranin I1"  Chromogranin A* 
Asx  13.71  _+ 0.95  8.0 
GIx  22.01  +  1.62  22.5 
Ser  6.42 +  0.45  7.7 
Thr  3.72 _+ 0.21  2.6 
Cys  n.a.  0.2 
Met  0.40 _+ 0.09  1.4 
Pro  5.90 _  1.08  9.2 
Gly  6.69 +  0.57  8.1 
Ala  5.05 _+ 0.52  8.5 
Val  3.80 +  0.60  3.9 
Leu  9.65 +  0.20  7.3 
lie  4.22 _-4-  0.18  1.4 
Phe  2.80 +  0.38  1.7 
Tyr  3.26 +  0.04  1.0 
Trp  n.a.  1.4 
Lys  6.92 _+ 1.51  8.4 
His  1.14 _+ 0.11  1.9 
Arg  4.30 _  0.51  6.0 
* Each  value is the average of three determinations +  SE. 
* Chromogranin A  data are taken from Cohn et al. (7). 
n.a.,  not analyzed. 
FIGURE  6  Phosphorylation and  sulfation  of secretogranin  I,  secretogranin  II,  and  chromogranin A.  [32P]Phosphate-labeled (A) 
and  [3SS]sulfate-labeled (B)  proteins of adrenal medullary cells were separated by two-dimensional  PAGE,  followed  by autora- 
diography (A)  and fluorography (B). Arrowheads, secretogranin I; arrows, secretogranin II; open arrows, chromogranin A; open 
arrow with  asterisk,  highly sulfated  form  of chromogranin  A.  The  identities of the  radiolabeled proteins with  secretogranin  I, 
secretogranin II, and chromogranin A  were determined by mixing and co-electrophoresis with the respective purified proteins. 
2004  THE JOURNAL OF  CELL BIOLOGY - VOLUME 101,  1985 TABLE II.  Tyrosine Sulfate Analysis of Secretogranin  I, 
Secretogranin II,  Chromogranin A, and Their Related Polypeptides 
[3ss]sulfate-labeled material 
3ss recovered  ass recovered 
after alkaline  as tyrosine 
hydrolysis  sulfate 
cpm  %  % 
Tyrosine [3SS]sulfate  2,340  80  66 
Secretogranin  I  1,395  52  42 
p94  639  41  34 
p90  594  51  52 
p82  355  45  41 
p67  450  52  47 
Secretogranin II  1,413  53  41 
p66  279  47  n.a. 
Chromogranin A  391  8  n.a. 
p92  1,813  2  n.a. 
Total protein of [3SS]sulfate-labeled  adrenal medullary cells was separated by 
two-dimensional  PAGE. [3sS]Sulfate-labeled  secretogranin I, secretogranin II, 
chromogranin  A, and their related polypeptides,  identified by mixing with 
unlabeled heat-stable chromaffin granule proteins, were excised from the gel 
and subjected to tyrosine sulfate analysis (21). Proteins were eluted  under 
pronase digestion, and the eluates were subjected to alkaline hydrolysis using 
barium hydroxide  followed by neutralization with sulfuric acid. The super- 
natant after neutralization was then analyzed by thin-layer  electrophoresis. 
The 3sS recovered in the neutral supernatant after alkaline hydrolysis and in 
the  tyrosine  sulfate  spot  after  thin-layer  electrophoresis  is  expressed in 
percentage of the 3ss found in the pronase eluate. 
n.a., not analyzed. 
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FIGURE  7  Depolarization-in- 
duced, calcium-dependent re- 
lease  of  secretogranin  I  and 
secretogranin  II  from  PC12 
cells. [ass]sulfate-labeled 
PC12  cells were incubated in 
Ca2+-containing  medium  in 
the  presence of either 5  mM 
K  + (r-~), 55  mM  K  + ([]), or  55 
mM K  + plus 10 mM Mg  2+ (.m). 
[3sS]Sulfate-labeled  secreto- 
granins  I  and  II  released into 
the medium as well as those present in the cells were quantitated 
after immunoprecipitation and SDS PAGE. The release of secreto- 
granin I (Sgl) and of secretogranin II  (Sgll)  is expressed as percent 
of  the  total  (medium  plus  cells)  secretogranin  I  and  of the  total 
secretogranin II, respectively. 
incorporated into  secretogranins I  and  II was recovered as 
tyrosine sulfate (Table II). This incomplete recovery and the 
tunicamycin result indicated the presence of O-linked sulfated 
oligosaccharide residues in addition  to tyrosine sulfate resi- 
dues  in  the  two  secretogranins.  The  various  polypeptides 
related to secretogranins I and  lI and chromogranin A  (see 
Figs.  2 and 4) were also phosphorylated and sulfated (Fig.  6, 
Table II). 
Secretion of Secretogranins  I and II 
Depolarization of [3SS]sulfate-labeled PC 12 cells resulted in 
the release of labeled secretogranins I and II into the medium 
(Fig.  7). The depolarization-induced release of secretogranins 
I  and  II  was  apparently  calcium-dependent  since  it  was 
blocked by the  presence of 10  mM  magnesium ions.  This 
condition  is  known  to  inhibit  depolarization-induced  cal- 
cium-dependent exocytosis (10) and was found to block the 
depolarization-induced  norepinephrine  release  (data  not 
shown). [35S]Sulfate-labeled  secretogranins I and II, as well as 
chromogranin A, were released into the medium upon depo- 
larization  of primary cultures  of bovine adrenal  medullary 
cells (data not shown). 
Occurrence  of Secretogranins  I and II in a  Wide 
Variety of Endocrine  and Neuronal Cells 
Secreting Peptides by the Regulated  Pathway 
In view of the presence of secretogranins I and ll in anterior 
pituitary and  adrenal  medulla,  we investigated the possible 
occurrence of the two secretogranins in other tissues contain- 
ing endocrine cells and in the brain. For this purpose, the two 
proteins were enriched from various rat tissues by immuno- 
precipitation and their presence subsequently investigated by 
immunoblotting (Fig.  8). 
Secretogranins  I  and  II were  detected  in  the  brain,  the 
duodenum, and the thyroid gland; secretogranin II was also 
detected in the pancreas. The relative proportion of secreto- 
granin I to secretogranin II was different in the various tissues. 
Secretogranin II was predominant in the brain and thyroid, 
and secretogranin I was predominant in the duodenum. The 
levels of  the two secretogranins in the submaxillary gland (Fig. 
8)  and  in  serum (data not  shown) were below the  limit of 
detection of the present immunoprecipitation/immunoblot- 
ting method.  The latter finding indicated that the observed 
amounts of secretogranins in the various tissue homogenates 
could not be explained by the presence of blood containing 
secretogranins. 
The occurrence of secretogranins I and II in a variety of rat 
tissues was further investigated by light microscopic immu- 
nocytochemistry (Figs.  9-12). Immunoreactivity for both or 
at least one of the two secretogranins was found in all of the 
various endocrine and neuronal tissues examined. In all cases, 
FIGURE  8  Presence of secretogranin I and secretogranin II in var- 
ious tissues of the  rat. Secretogranin  I  and  secretogranin II  were 
enriched  from  total  homogenates of  rat  brain  (4,320  #g  protein, 
lane 2),  pancreas (4,165 ~g protein, lane 3),  duodenum (3,885 #g 
of protein, lane 4), thyroid (1,600/zg protein, lane 5), and submax- 
illary gland (4,000 #g of protein, lane 6)  by immunoprecipitation, 
using a  mixture of anti-rat secretogranin I antiserum and anti-rat 
secretogranin II antiserum. The immunoprecipitates and, as refer- 
ences, homogenates of rat pituitary (100 #g protein, lane I) and of 
PCl 2 cells (40/~g protein, lane 7) were analyzed by one-dimensional 
immunoblotting, using a I :I mixture of either anti-rat secretogranin 
I  antiserum  and  anti-rat  secretogranin  II  antiserum  (top)  or  the 
respective  preimmune  sera  (bottom).  Only  the  portions  of  the 
immunoblots containing secretogranin I (Sgl)  and secretogranin II 
(Sgll) are shown. The exposure times of the fluorograms of lanes  7 
and 7 and lanes 2-6 were 4 h and 30 h, respectively. 
RosA IT AL.  Secretogranins  I and II  2005 FIGURE  9  Presence  of  secretogranin  I  and  secretogranin  II  in  the  rat  anterior  pituitary  and  adrenal gland  as  revealed  by 
immunofluorescence. (a and b) Serial plastic sections (1-/zm thick) of rat anterior pituitary immunostained with anti-rat secreto- 
granin I antiserum (1:10 dilution, a) and anti-rat secretogranin II antiserum (1:10 dilution, b). Many, but not all cells are stained 
by both antisera. Positive cells exhibit variable degrees of immunoreactivity. Some cells that contain high levels of secretogranin 
I (arrowheads, a) contain only low levels of secretogranin II (arrowheads, b). Some cells that contain high levels of secretogranin 
II  (arrow, b) contain only low levels of secretogranin I (arrows, a). (c and d) Frozen sections (20-#m thick) of rat adrenal gland 
immunostained with anti-rat secretogranin I antiserum (1:10 dilution, c) and anti-rat secretogranin II antiserum (1:10 dilution, d). 
Most cells of the medulla (M) but not cells of the cortex (C) are brightly immunostained for both secretogranins. Groups of poorly 
stained chromaffin cells are indicated by asterisks.  (a and b) Bars, 20/zm. x  600. (c and d) Bars, 50 #m. x  256. 
the immunoreactivity exhibited a  punctate appearance (visi- 
ble at higher  magnification)  consistent  with  the localization 
of these proteins in secretory granules (compare reference 38). 
In line with  the previously reported  distribution  of secre- 
togranin  II in the bovine anterior pituitary (38), this protein 
was found to be present,  at variable concentration,  in  many 
but not all cells of the rat anterior pituitary.  Secretogranin  I 
was  found  to  have  a  similar  distribution,  and  most  cells 
unstained  by anti-secretogranin  II antiserum  were  also  un- 
stained by anti-secretogranin I antiserum (Fig. 9, a and b). In 
positive cells,  the relative proportion  of secretogranin  I  and 
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secretogranin II immunoreactivity varied. Staining of adjacent 
1-~m-thick  plastic sections revealed that many cells that were 
only  moderately  stained  for  secretogranin  I  were  heavily 
stained for secretogranin II, and vice-versa. 
In the  adrenal  gland,  cells of the  medulla  but  not  of the 
cortex were immunoreactive (Fig.  9,  c and d).  Not all chro- 
maffin cells,  however, contained  the same amount of secre- 
togranins.  Two subpopulations  of chromaffin cells could  be 
identified  with  both  anti-secretogranin  I  and  anti-secreto- 
granin  II antisera,  one with  a  lower and  one  with  a  higher 
content of secretogranins. FIGURE  10  Presence of secretogranin I and secretogranin II  in the rat duodenum as revealed by immunofluorescence. 10-urn- 
thick  frozen  sections  immunostained with  anti-rat secretogranin  I antiserum (a and c)  and anti-rat secretogranin  II  (b and  d) 
antiserum. Secretogranin I immunoreactivity is concentrated in, and confined to, cells scattered in the mucosal epithelium, which 
have the characteristics of the typical endocrine cells of the gut (arrowheads, a). Secretogranin II can also be detected in some 
of these cells, but is present in very low levels (arrowheads, b). In addition, secretogranin II is concentrated in neuronal varicosities 
(arrows,  b).  c  and d  show higher magnifications of immunoreactive mucosal cells  illustrating the  punctate appearance of the 
immunostain, d has been printed at much higher contrast than c to better visualize the staining pattern, (a and b) Bars, 20 urn.  x 
461. (cand d) Bars, 10 ~,m. x  1,440. 
Both secretogranins were detectable in the scattered endo- 
crine cells of the mucosa in all portions of the stomach (data 
not shown)  and  duodenum  (Fig.  10). The  high  number of 
immunoreactive cells suggested that most, if not all, endocrine 
cells were stained, irrespective of  the type of regulatory peptide 
secreted. In the wall of the duodenum, immunoreactivity for 
the two secretogranins showed remarkable differences in dis- 
tribution.  In the mucosal endocrine cells of the duodenum, 
secretogranin I immunoreactivity was much more prominent 
than secretogranin II immunoreactivity. Secretogranin II was 
also detectable in neuronal elements throughout the intestinal 
wall  (Fig.  10). Neurons  of the  Auerbach  and  submucosal 
plexus, as well as varicosities throughout the muscular, sub- 
mucosal, and mucosal layers were stained. No secretogranin 
I immunoreactivity was observed in neuronal elements, even 
in sections that contained heavily stained endocrine mucosal 
cells. 
In the pancreas, low levels of secretogranin II but not of 
secretogranin I were seen in the endocrine islands (not shown). 
In addition, stained axonal varicosities were visible through- 
out the tissue.  In the thyroid, secretogranin II was detectable 
in parafollicular cells and in axonal varicosities (not shown). 
Immunoreactivity for both secretogranins was widespread 
throughout the central nervous system and was very promi- 
nent  in  certain  regions.  In  all  regions,  the  distribution  of 
immunoreactivity suggested a  localization of secretogranins 
in neuronal processes and/or perikarya. Low power views of 
immunoperoxidase-stained coronal sections of the brain (Fig. 
1 l) revealed that both secretogranins were more concentrated 
in the phylogenetically older portions of the brain, i.e., those 
Rosa ET At_.  Secretogranins  I and II  2007 FIGURE 11  Presence of secretogranin I and secretogranin II in the ventral regions of the rat brain as revealed by immunoperox- 
idase.  15-/~m-thick  frozen coronal sections immunostained with anti-rat secretogranin I antiserum (A) and anti-rat secretogranin 
II  antiserum (B). Peroxidase reaction  product,  which  appears black  in  the  micrographs,  is concentrated  in  several areas  that 
include the hypothalamus (by) and the amygdaloid complex (ac). Note differences between distribution of immunoreactivity for 
secretogranin I (A) and secretogranin II (B). or, optic tract; oc, olfactory cortex; ic, internal capsule. (A and B) Bars, I  mm. x  12.1. 
known to be most enriched in peptide neurotransmitters (24). 
Areas more  enriched  in  secretogranins  included  the  hypo- 
thalamus, the amygdala, the caudate-putamen, the olfactory 
cortex,  and,  in  particular,  the  mossy  fiber  system  of the 
hippocampus (Fig.  12). Inside major brain regions, the distri- 
bution  of the  two  secretogranins  was  not  identical.  Clear 
differences were visible, for example, in  ventral portions of 
the brain (Fig.  11). Differences were even more evident when 
individual brain regions were examined at higher magnifica- 
tion (not shown). The meshwork of processes that were im- 
munoreactive for secretogranins I and II often had different 
patterns.  In  addition,  the  relative  proportion  of stain  on 
perikarya and cell processes was also variable. For example, 
in some neocortical areas, immunoreactivity for secretogranin 
I was more concentrated in perikarya, while that for secreto- 
granin II was more concentrated in fine varicose processes. 
DISCUSSION 
The present study reports on a major feature of most endo- 
crine and neuronal cells that secrete peptides by the regulated 
pathway: these cells contain, in addition to the specific peptide 
hormone or neuropeptide secreted, at least one member of 
the  secretogranin/chromogranin  class  of proteins.  It is  the 
presence of this class of proteins rather than the presence of 
any one member which marks these cells. Three members of 
this  protein  class,  which  are  not  necessarily the  only ones 
existing, are known to date: (a) chromogranin A, which was 
first  characterized  in  the  adrenal  medulla  (for reviews see 
references 44  and  45);  (b)  secretogranin  II, which  was first 
characterized in the anterior pituitary (36, 48);  and (c) secre- 
togranin I, which was first characterized in PCI2 cells (27). 
(The  latter  protein  has  also  been  called  chromogranin  B 
because of its presence in  chromaffin granules (12,  15,  46). 
However, the  name chromogranin B has also been used to 
refer to a degradation product of chromogranin A [34].) 
Secretogranin I, Secretogranin  II, and 
Chromogranin A Are Distinct Proteins 
Our results establish that secretogranin I, secretogranin II, 
and chromogranin A are distinct, and exclude the possibility 
that  they are  related to  each other  by a  precursor-product 
relationship. Antisera against either secretogranin I, secreto- 
granin II, or chromogranin A can be raised which specifically 
recognize the respective antigen and its proteolytic fragments. 
Moreover, the  fingerprints of the  three proteins are clearly 
different and suggest that the individual mRNAs existing for 
the three proteins (Fig.  5; references 12 and  39)  must code 
for, on  the  whole,  distinct  protein sequences.  Nevertheless, 
the three proteins seem to contain at least a few homologous 
segments (40),  which would explain why we have sometimes 
observed  cross-reactivities  between  antisera  raised  against 
Coomassie  Blue-stained  antigens  (unpublished  data).  The 
three proteins are differentially expressed in various cells. For 
example, secretogranin II but not secretogranin I is present in 
axonal varicosities of the duodenum (Fig.  10). In PC12 cells, 
secretogranin I- and II-mRNAs, but little if any chromogranin 
A-mRNA, are found (Fig.  5). It will  therefore be important 
to determine whether the distinct mRNAs for secretogranins 
I and II and chromogranin A and the different levels of these 
mRNAs in  various cells  result  from cell-specific,  extensive 
alternating splicing of a single primary transcript or from cell- 
specific expression of different genes. 
Secretogranin  I, Secretogranin  II, and 
Chromogranin A Belong to One Class of Proteins 
Although  secretogranin  I,  secretogranin  II, and  chromo- 
granin A are distinct proteins, they have three key features in 
common, suggesting that they exert the same function. First, 
all three proteins are very acidic, with pI values between 4.2 
and 5.2. They are not only rich in acidic amino acids but are 
also posttranslationally modified by addition of  strongly acidic 
sulfate and  phosphate groups.  The proteolytic fragments of 
the three proteins have pI values very similar to the parent 
proteins, as if acidic groups were spaced at repetitive intervals 
in the molecules. 
Second, all three proteins are secretory. After their synthesis 
by membrane-bound polysomes of the  rough  endoplasmic 
reticulum, they pass through the Golgi complex where they 
become phosphorylated and sulfated, and are then specifically 
sorted into secretory granules. All  three proteins, as well as 
proteolytic fragments of these proteins arising during intra- 
cellular transport and storage, are released upon appropriate 
stimulation of secretion. 
Third, secretogranins I and II, like chromogranin A (8, 33, 
41),  selectively occur  in  a  wide  variety  of endocrine  and 
neuronal  cells  secreting peptides by the  regulated pathway. 
Although each of these three proteins has a wide distribution, 
none occurs in all peptide-secreting endocrine and neuronal 
cells.  However, the distribution of these proteins is not only 
2008  THE  JOURNAL OF  CELL BIOLOGY • VOLUME  101,  1985 FIGURE 12  Presence of secretogranin I and secretogranin II  in the mossy fiber system of the rat hippocampus as revealed by 
immunoperoxidase. 15-#m-thick frozen coronal sections stained with anti-rat secretogranin I antiserum (A) and anti-rat secreto- 
granin II antiserum (B). The hylus of the hippocampus with the dentate gyrus (DG) and the CA4-CA3  region of the pyramidal cell 
layer (PC) are shown. Peroxidase reaction product, which appears black in the micrographs, is visible as punctate staining highly 
concentrated at sites that correspond in distribution to mossy fiber terminals (m/). (A and B) Bars, 200 #m. x  86.4. 
ROSA lET AL.  Secretogranins  I and II  2009 overlapping  but  also  complementary,  as  illustrated  in  this 
study for secretogranins I and II. Therefore, the distribution 
of this class of proteins is more widespread than that of any 
one of its members. The three proteins are not detected in 
cells secreting peptides by  nonregulated pathways, in endo- 
crine cells secreting nonpeptide hormones, and do not appear 
to be present in exocrine cells. 
Relationship of the Secretogranin/Chromogranin 
Class of Proteins to Sulfated Proteogl)/cans 
of Secretory Granules 
Chromaffin cells (see the open arrow with asterisk in Fig. 
6)  and  anterior pituitary  cells  (data  not  shown) contain  a 
highly sulfated, tunicamycin-resistant component. This com- 
ponent appears to be a highly sulfated form of chromogranin 
A (Figs. 2 and 4). Interestingly, this highly sulfated component 
also appears to correspond to one of the sulfated proteoglycans 
known to exist in chromaffin granules (23)  since it can be 
digested with chondroitinase ABC (13). Together, these results 
suggest that the core protein of this proteoglycan is related to 
chromogranin A and raise the possibility of an interrelation- 
ship between sulfated proteoglycans of secretory granules and 
the secretogranin/chromogranin class of proteins. 
Possible Functions of the Secretogranin[ 
Chromogranin Class of Proteins 
Proposals for the as yet unknown function of secretogranin 
I, secretogranin II, and chromogranin A should be reconciled 
with the specific occurrence of this class of proteins in secre- 
tory granules of a  wide  variety  of endocrine and  neuronal 
cells secreting peptides by the regulated pathway. It may be 
that these proteins function after secretion, for example  as 
carder proteins for regulatory peptides or as regulatory pro- 
teins themselves. One may also think of a role of  these proteins 
in the secretory process of regulatory peptides, for example as 
processing enzymes or as helper proteins in the packaging of 
regulatory peptides  into  secretory granules  (38).  The  latter 
role, although not proven, seems particularly attractive since 
it can be well reconciled with both the highly acidic nature of 
these proteins and the apparent relationship of at least one of 
these proteins, chromogranin A, to sulfated proteoglycans of 
secretory granules. The latter macromolecules have previously 
been proposed to be involved, by means of their high density 
of negative charges, in the packaging of proteins into secretory 
granules (14,  47).  The  secretogranin/chromogranin class of 
proteins would be similar to sulfated proteoglycans in that 
they,  too,  will  carry a  large  number of negatively charged 
residues at the acidic pH of the trans cisternae of the Golgi 
complex (2), the compartment with a key role in the packaging 
of regulatory peptides. 
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